首页> 美国卫生研究院文献>PLoS Clinical Trials >Amyloid-Like Fibril Formation by PolyQ Proteins: A Critical Balance between the PolyQ Length and the Constraints Imposed by the Host Protein
【2h】

Amyloid-Like Fibril Formation by PolyQ Proteins: A Critical Balance between the PolyQ Length and the Constraints Imposed by the Host Protein

机译:PolyQ蛋白形成类似淀粉样的原纤维:PolyQ长度与宿主蛋白施加的约束之间的关键平衡

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Nine neurodegenerative disorders, called polyglutamine (polyQ) diseases, are characterized by the formation of intranuclear amyloid-like aggregates by nine proteins containing a polyQ tract above a threshold length. These insoluble aggregates and/or some of their soluble precursors are thought to play a role in the pathogenesis. The mechanism by which polyQ expansions trigger the aggregation of the relevant proteins remains, however, unclear. In this work, polyQ tracts of different lengths were inserted into a solvent-exposed loop of the β-lactamase BlaP and the effects of these insertions on the properties of BlaP were investigated by a range of biophysical techniques. The insertion of up to 79 glutamines does not modify the structure of BlaP; it does, however, significantly destabilize the enzyme. The extent of destabilization is largely independent of the polyQ length, allowing us to study independently the effects intrinsic to the polyQ length and those related to the structural integrity of BlaP on the aggregating properties of the chimeras. Only chimeras with 55Q and 79Q readily form amyloid-like fibrils; therefore, similarly to the proteins associated with diseases, there is a threshold number of glutamines above which the chimeras aggregate into amyloid-like fibrils. Most importantly, the chimera containing 79Q forms amyloid-like fibrils at the same rate whether BlaP is folded or not, whereas the 55Q chimera aggregates into amyloid-like fibrils only if BlaP is unfolded. The threshold value for amyloid-like fibril formation depends, therefore, on the structural integrity of the β-lactamase moiety and thus on the steric and/or conformational constraints applied to the polyQ tract. These constraints have, however, no significant effect on the propensity of the 79Q tract to trigger fibril formation. These results suggest that the influence of the protein context on the aggregating properties of polyQ disease-associated proteins could be negligible when the latter contain particularly long polyQ tracts.
机译:九种神经退行性疾病称为多谷氨酰胺(polyQ)疾病,其特征是由九种含有超过阈值长度的polyQ束的蛋白质形成核内淀粉样样聚集体。这些不溶性聚集体和/或其一些可溶前体被认为在发病机理中起作用。 polyQ扩展触发相关蛋白质聚集的机制仍然不清楚。在这项工作中,将不同长度的polyQ片段插入到溶剂暴露的β-内酰胺酶BlaP环中,并通过一系列生物物理技术研究了这些插入对BlaP性质的影响。插入多达79个谷氨酰胺不会改变BlaP的结构;但是,它确实使酶不稳定。不稳定的程度在很大程度上与polyQ长度无关,这使我们能够独立研究polyQ长度固有的影响以及与BlaP结构完整性有关的对嵌合体聚集特性的影响。只有具有55Q和79Q的嵌合体容易形成淀粉样蛋白原纤维。因此,类似于与疾病相关的蛋白质,存在一定数量的谷氨酰胺,在此阈值以上,嵌合体聚集成淀粉样蛋白原纤维。最重要的是,无论BlaP是否折叠,含有79Q的嵌合体均以相同的速率形成淀粉样样原纤维,而仅当BlaP折叠时,55Q嵌合体才会聚集成淀粉样样原纤维。因此,淀粉样蛋白样原纤维形成的阈值取决于β-内酰胺酶部分的结构完整性,并因此取决于施加于polyQ束的空间和/或构象约束。但是,这些限制条件对79Q束触发原纤维形成的倾向没有显着影响。这些结果表明,当蛋白质中包含特别长的polyQ片段时,蛋白质环境对与polyQ疾病相关的蛋白质聚集特性的影响可以忽略不计。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号